A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma

Clinical Cancer Research

Volumn 13, Issue 22, 2007, Pages 6658-6665

  Myoung, Sook Kim ^a   Yamashita, Keishi ^a   Young, Kwang Chae ^a   Tokumaru, Yutaka ^a   Chang, Xiaofei ^a   Zahurak, Marianna ^a   Osada, Motonobu ^a   Park, Hannah Lui ^a   Chuang, Alice ^a   Califano, Joseph A ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; TUMOR MARKER;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER PATIENT; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE; HUMAN; HUMAN TISSUE; MALE; METHYLATION; OUTCOME ASSESSMENT; PATHOLOGY; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; QUANTITATIVE ANALYSIS; RESTRICTION MAPPING; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TRANSCRIPTION INITIATION SITE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); RECEPTORS, N-METHYL-D-ASPARTATE; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 36749032648     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1178     Document Type: Article

References (28)

1. Messmann H. Squamous cell cancer of the oesophagus. Best Pract Res Clin Gastroenterol 2001;15:249-65.
2. Kuwano H, Nakajima M, Miyazaki T, Kato H. Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg 2003;9:6-13.
3. Montesano R, Hainaut P. Molecular precursor lesions in oesophageal cancer. Cancer Surv 1998;32:53-68.
4. Launoy G, Milan C, Day NE, Faivre J, Pienkowski P, Gignoux M. Oesophageal cancer in France: potential importance of hot alcoholic drinks. Int J Cancer 1997;71:917-23.
5. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992;52:2980-3.
6. Merlo A, Herman J, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
7. Kuroki T, Trapasso F, Yendamuri S, et al. Allele loss and promoter hypermethylation of VHL, RAR-b, RASSF1A, FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003;64:3724-28.
8. Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. A tumor suppressive role for trypsin in human cancer progression. Cancer Res 2003;63:6575-8.
9. Nie Y, Yang G, Song Y, et al. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001;22:1615-23.
10. 6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 2003;24:1039-44.
11. Boehning D, Snyder S. Novel neural modulators. Annu Rev Neurosci 2003;26:105-31.
12. Grozdanovic Z, Gossrau R. Co-localization of nitric oxide synthase I (NOS I) and NMDA receptor subunit 1 (NMDAR-1) at the neuromuscular junction in rat and mouse skeletal muscle. Cell Tissue Res 1998;291:57-63.
13. Lin YJ, Bovetto S, Carver JM, Giordano T. Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery. Brain Res Mol Brain Res 1996;43:57-64.
14. Nahm WK, Philpot BD, Adams MM, et al. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol 2004;200:309-17.
15. Sinclair PB, Sorour A, Martineau M, et al. A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res 2004;64:4089-98.
16. Rush LJ, Raval A, Funchain P, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004;64:2424-33.
17. Kim MS, Yamashita K, Baek JH, et al. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res 2006;66:3409-18.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-80.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
20. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B 1972;34:187-220.
21. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992;69:1088-93.
22. Brock MV, Gou M, Akiyama Y, et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 2003;9:2912-9.
23. Esteller M, Sanchez-Cespedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from nonsmall cell lung cancer patients. Cancer Res 1999;59:67-70.
24. Kawakami K, Brabender J, Lord RV, et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000;92:1805-11.
25. Sanchez-Cespedes M, Esteller M, Wu, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000;60:892-5.
26. Jeronimo C, Usadel H, Henrique R, et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 2001;93:1747-52.
27. Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
28. Mandelker DL, Yamashita K, Tokumaru Y, et al. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 2005;65:4963-8.